This study evaluates the effectiveness of fimasartan-based antihypertensive treatment and prognosis in post-acute phase of ischemic stroke or transient ischemic attack patients. All participants will receive fimasartan, and the investigators will follow them up for 6 months.
Study Type
OBSERVATIONAL
Enrollment
1,035
Korea University Ansan Hospital
Ansan, South Korea
BP
Blood pressure control rate(\<140/90 mmHg)
Time frame: 24 weeks
BP
Blood pressure control rate(\<140/90 mmHg)
Time frame: 4, 12 weeks
BP
Blood pressure changes
Time frame: 4, 12, 24 weeks
mRS
mRS changes
Time frame: 4, 12, 24 weeks
Fimasartan-based treatment
Fimasartan-based treatment modalities
Time frame: 24 weeks
Fimasartan starting point
Fimasartan starting point after stroke
Time frame: 24 weeks
Stroke recurrence
Rate of stroke recurrence
Time frame: 24 weeks
Cardiovascular events
Incidence of cardiovascular events
Time frame: 24 weeks
Mortality rates from cardiovascular disease
Mortality rates from cardiovascular disease
Time frame: 24 weeks
Mortality rates of any cause
Mortality rates of any cause
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hallym University Medical Center
Anyang, South Korea
Dong-A University Hospital
Busan, South Korea
Inje University Busan Paik Hospital
Busan, South Korea
Pusan National University Hospital
Busan, South Korea
Keimyung University Dongsan Medical Center
Daegu, South Korea
Kyungpook National University Hospital
Daegu, South Korea
Daejeon Eulji Medical Center
Daejeon, South Korea
Inje University Ilsan Paik Hospital
Goyang, South Korea
Myongji Hospital
Goyang, South Korea
...and 17 more locations
Time frame: 24 weeks
Adverse events
Adverse events related to antihypertensive treatments
Time frame: 24 weeks